Tracey L. O’Connor

Also affiliated with Roswell Park Comprehensive Cancer Center, Moffitt Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.271Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Papers

Driven by 12 papers — median percentile 21. Top paper: “Determinants of response to CDK4/6 inhibitors in the real-world setting”.

Determinants of response to CDK4/6 inhibitors in the real-world setting

npj Precision Oncology(2023)10.1038/s41698-023-00438-0

N/A

0.745DataRank · unranked

25 citations

Emily Schultz, Jianxin Wang, Deanna Hamilton, Ellis Levine, Tracey L. O’Connor +2 more

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

npj Breast Cancer(2023)10.1038/s41523-022-00504-z

N/A

0.705DataRank · unranked

23 citations

Donald W. Northfelt, Tracey L. O’Connor, Ellis Levine, Jingqin Luo, Yu Tao +16 more

Falls prechemotherapy and toxicity‐related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial

Cancer(2023)10.1002/cncr.35105

N/A

0.485DataRank · unranked

11 citations

Marie Bae, Can‐Lan Sun, Tanya M. Wildes, Rachel A. Freedman, Allison Magnuson +14 more

Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)

Journal of Geriatric Oncology(2024)10.1016/j.jgo.2024.101813

N/A

0.402DataRank · unranked

7 citations

Minji K. Lee, Jingran Ji, Daniel Satele, Rachel A. Freedman, Philip D. Poorvu +12 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007381

N/A

0DataRank · unranked

18 citations

Mateusz Opyrchal, Melissa Grimm, Ronald Slomba, Kathleen M. Kokolus, Agnieszka K. Witkiewicz +13 more

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience

Frontiers in Oncology(2022)10.3389/fonc.2022.1012391

N/A

0DataRank · unranked

18 citations

Arya Mariam Roy, Kristopher Attwood, Anthony George, Tracey L. O’Connor, Amy Early +3 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study

Journal of Cancer Survivorship(2024)10.1007/s11764-024-01594-3

N/A

0DataRank · unranked

13 citations

Can‐Lan Sun, Marie Bae, Rachel A. Freedman, Allison Magnuson, Tracey L. O’Connor +14 more

Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-010058

N/A

0DataRank · unranked

8 citations

Ronald Slomba, Cayla Janes, Victoria Fitzpatrick, Janine Miller, Kristopher Attwood +19 more

Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12042

N/A

0DataRank · unranked

2 citations

Can‐Lan Sun, William Dale, Harvey Jay Cohen, Hyman B. Muss, Allison Magnuson +6 more

CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin

Cardio-Oncology(2021)10.1186/s40959-021-00103-0

N/A

0DataRank · unranked

14 citations

Badri Karthikeyan, Adolfo Quiñones‐Lombraña, Rachael Hageman Blair, Amy Early, Ellis Levine +4 more

Tracey L. O’Connor

Indexed papers

Top data-sharing exemplar

Papers